Blue Bell Private Wealth Management’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
Other funds holding VRTX
Blue Bell Private Wealth Management's VRTX Position: Q3 2022 in Review
Blue Bell Private Wealth Management sold out of Vertex Pharmaceuticals (VRTX) in Q3 2022, closing a stake of 10 shares — an estimated $3K sold.
Blue Bell Private Wealth Management first reported a position in VRTX in Q4 2021 and held it in 3 quarters. The position peaked at $3K in Q2 2022. 1,126 funds tracked by Wall St. Rank hold VRTX as of Q3 2022.
- Blue Bell Private Wealth Management reported no remaining Vertex Pharmaceuticals position as of Q3 2022 after selling out during the quarter.
- Blue Bell Private Wealth Management sold 10 Vertex Pharmaceuticals shares in Q3 2022, an estimated $3K.
- Blue Bell Private Wealth Management first reported a position in Vertex Pharmaceuticals in Q4 2021 and held it in 3 quarters.
- Blue Bell Private Wealth Management's Vertex Pharmaceuticals position peaked at $3K in Q2 2022.
- 1,126 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q3 2022.
Based on Blue Bell Private Wealth Management's 13F filing for Q3 2022, filed 9 Nov 2022.